EXEL Maintained by Citizens -- Price Target Raised to $65.00

gurufocus.com · 2026-10-19

Exelixis (EXEL) Analyst Rating Update - October 19, 2026 On October 19, 2026, Citizens maintained a 'Market Outperform' rating on Exelixis (EXEL), raising th

TickrTrends take: Citizens maintained its rating on EXEL while raising the price target to $65, which provides a data point for assessing whether the stock's current market price aligns with analyst expectations in the Healthcare sector. Given TickrTrends' fairly valued assessment, this price target adjustment may indicate how the market is pricing in recent developments relative to fundamental value. Valuation-focused readers should monitor whether the stock trades toward or away from this $65 target, as such movement could signal shifts in how the market perceives EXEL's worth relative to its peers in Healthcare.

Read the full story at gurufocus.com →